Research Mentor Name

Paul Naylor

Research Mentor Email Address

pnaylor@med.wayne.edu

Institution / Department

DMC/ Department of Gastroenterology

Document Type

Research Abstract

Research Type

clinicalresearch

Level of Research

no

Abstract

The objective of this study was to determine whether there were different characteristics between HCV patients who were treated and those not treated after their first visit to a Gastroenterology (GI) or Infectious Disease (ID) clinic. This information might identify potential targets for remedial actions that could be performed to increase the number of treated patients.

Data was collected from 2019 HCV patient EMR charts including patient demographics, treatment history, and laboratory studies. We defined success as receiving treatment by July 2020 (6-18 months after the first visit).

We found that of 587 patients with HCV who were seen at least once in the Wayne Health system, 441 patients (441/587=75%) were not treated and only 189 (189/441= 43%) were treated by July 2020. Treated and not treated patients were similar with respect to race, gender, age, and median income defined by zip code. They were also not different with respect to the clinic seen (ID vs GI), the type of insurance, or the degree of fibrosis. However, patients with an average of 4 visits were more likely to be treated than those having 2 visits. Having 1 visit was the most dramatic factor in the lack of treatment (42% vs 8% p<0.0001). PCR available at first visit was an important factor with respect to treatment (treated 38% vs not treated 25% p<0.02).

Disciplines

Medicine and Health Sciences

Share

COinS